Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Boditech Med Inc. (206640:KRX), powered by AI.
Boditech Med Inc. is currently trading at ₩10,950. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Boditech Med Inc. on Alpha Lenz.
Boditech Med Inc.'s P/E ratio is 10.1.
“Boditech Med Inc. trades at a P/E of 10.1 (undervalued) with solid ROE of 10.7%. 3Y revenue CAGR of 11.1% highlights clear growth momentum.”
Ask for details →Boditech Med Inc. specializes in the development and manufacturing of in-vitro diagnostic products and medical devices. The company's primary focus is providing point-of-care testing solutions that offer quick and accurate diagnostic results. These solutions are essential in clinical settings, enabling healthcare professionals to make timely decisions for patient care. Boditech Med is known for its advanced immunoassay analyzers, which are used to detect diseases across various sectors, including infectious diseases, heart conditions, and cancer. The company's products serve a broad range of markets, from hospitals and clinics to laboratories and research facilities globally. By addressing the demand for efficient diagnostics, Boditech Med plays a pivotal role in enhancing healthcare services and improving patient outcomes. Its commitment to innovation positions it as a significant contributor in the medical devices industry, reflecting its influence on global health markets and advancing the accessibility of healthcare innovations.
“Boditech Med Inc. trades at a P/E of 10.1 (undervalued) with solid ROE of 10.7%. 3Y revenue CAGR of 11.1% highlights clear growth momentum.”
Ask for details →Boditech Med Inc. (ticker: 206640) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 515 employees. Market cap is $239.9B.
The current price is ₩10,950 with a P/E ratio of 10.14x and P/B of 1.04x.
ROE is 10.71% and operating margin is 17.85%. Annual revenue is $162.1B.